Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Sanara MedTech Enters Merger Agreement with MiMedx

Sanara MedTech Inc. filed an amended Form 8-K/A on August 11, 2026, correcting termination fee amounts reported in its original July 29, 2026 current report disclosing an Agreement and Plan of Merger with MiMedx Group, Inc.

Nitish Kishor | 11 August 2026

Boston Beer Enters $25M Stock Repurchase Plan

The Boston Beer Company, Inc. filed an 8-K on August 11, 2026, disclosing that it entered into a 10b5-1 plan on August 10, 2026, to repurchase up to $25 million of its Class A Common Stock between September 28, 2026, and December 25, 2026.

Nitish Kishor | 11 August 2026

Aquestive Therapeutics Reports Q2 2026 Financial Results

Aquestive Therapeutics, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 11, 2026, reporting its financial results for the second quarter ended June 30, 2026, and disclosing an investor presentation furnished under Regulation FD.

Anjali Anand | 11 August 2026

AnaptysBio 2026 Annual Meeting Voting Results

AnaptysBio, Inc. filed an 8-K on August 11, 2026, reporting the voting outcomes from its 2026 Annual Meeting of Stockholders held that same day on four separate proposals.

Nitish Kishor | 11 August 2026

Burke & Herbert CFO Receives Change in Control Agreement

Burke & Herbert Financial Services Corp. filed a Form 8-K on August 11, 2026, disclosing that it entered into a change in control agreement with Executive Vice President and Chief Financial Officer Kirtan Parikh, effective July 6, 2026.

Shwetambri Chauhan | 11 August 2026

Super Micro Computer Reports Q4 and Full Fiscal Year 2026 Results

Super Micro Computer, Inc. filed a Form 8-K with the SEC on August 11, 2026, announcing unaudited financial results for the quarter and full fiscal year ended June 30, 2026, via an attached press release.

Aditi Sarkar | 11 August 2026

Mineralys Therapeutics Names New Chief Medical Officer

Mineralys Therapeutics, Inc. filed a Form 8-K on August 11, 2026, disclosing the appointment of a new Chief Medical Officer effective August 10, 2026, and announcing financial results for the quarter ended June 30, 2026.

Manish Choudhary | 11 August 2026

Griffon Corporation Prices $800M Senior Notes Due 2034

Griffon Corporation filed a Form 8-K with the SEC on August 11, 2026, disclosing that on August 10, 2026, the company entered into a Purchase Agreement to issue and sell $800 million aggregate principal amount of 6.25% senior notes due 2034.

Vinay Lochav | 11 August 2026

DoorDash CEO Tony Xu Reports Class A Stock Changes

A Form 4 filed with the SEC on August 11, 2026, discloses changes in beneficial ownership of DoorDash, Inc. (NASDAQ:DASH) Class A Common Stock by Chief Executive Officer and Director Tony Xu, reflecting transactions dated August 7, 2026.

Manish Choudhary | 11 August 2026

DoorDash Stockholders Approve Nevada Reincorporation

DoorDash, Inc. filed a Form 8-K on August 11, 2026, disclosing that certain stockholders holding a majority of voting power approved the company's reincorporation from Delaware to Nevada by written consent on August 6, 2026.

Anjali Anand | 11 August 2026
Support

Hi! How can we help you today?

Loading…